Lagos — Chevron Corporation (NYSE: CVX) has announced its partnership with National Agency for the Control of AIDS (NACA), as part of its $30 million commitment to the Global Fund to Fight AIDS, Tuberculosis and Malaria.
NACA will receive a total of $5 million over the next three years, to help fight HIV/AIDS as part of a Round Five grant from the Global Fund.
According to a recent UNAIDS report in 2007, approximately 170,000 people in Nigeria died from AIDS. And over the past 16 years, the disease has reduced the national life expectancy for women by eight years and men by six years.
"The HIV/AIDS epidemic continues to threaten the health and economic prosperity of our country," said Professor Babatunde Osotimehin, former Director General, NACA and now Nigeria's Minister of Health. "This year, we plan to significantly scale up the national response through strategic partnerships - particularly with the private sector, in our fight against this epidemic," he said.
Through the Global Fund Round Five HIV/AIDS grant to Nigeria, NACA has established 111 service delivery points that provide AIDS treatment (Antire-troviral treatment - ARV). With the additional delivery points, NACA had been able to provide ARV treatment to more than 50,000 people, while over 6,000 pregnant women had received treatment for the prevention of mother-to-child transmission of HIV.
"NACA shares our belief that community action and effective partnerships are required to stop the spread of HIV/AIDS," said Andrew Fawthrop, Managing Director - Nigeria Mid-Africa Strategic Business Unit. "We intend to continue working with NACA and other partners to leverage our human capacity in support of sustainable initiatives that are directed towards prevention and treatment of HIV/AIDS and improve the lives of those living with the virus in Nigeria."